Emerging diagnostic tests for vitreoretinal lymphoma: a review

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Vitreoretinal lymphoma, which most commonly is diffuse large B-cell non-Hodgkin in type, is a rare cancer with high morbidity and high mortality. Making a tissue diagnosis of vitreoretinal lymphoma is a major challenge for clinicians due to biological and technical factors. Yet, the delay in start of treatment may have vision- and life-threatening consequences, and there is considerable interest in the application of molecular assays to improve the accuracy of the diagnostic process: detection of a clonal immunoglobulin heavy-chain rearrangements in lymphoma cells by polymerase chain reaction; measurement of vitreous or aqueous interleukin-10 protein levels in ocular fluids; and identification of mutations in the myeloid differentiation primary response gene 88 in tumour cells. In this article, we review the historical development and current application of each of these molecular methods. We also discuss future opportunities for the molecular diagnosis of vitreoretinal lymphoma through next-generation sequencing technologies.

Original languageEnglish
Pages (from-to)945-954
Number of pages10
JournalClinical and Experimental Ophthalmology
Volume46
Issue number8
Early online date2018
DOIs
Publication statusPublished - 13 Apr 2018

Keywords

  • Diagnostic technique
  • Lymphoma
  • Retina

Fingerprint Dive into the research topics of 'Emerging diagnostic tests for vitreoretinal lymphoma: a review'. Together they form a unique fingerprint.

  • Cite this